Donate now
EN FR
17 February 2023
Lung cancer

IARC scientists awarded grant to continue research on neuroendocrine tumours

Scientists at the International Agency for Research on Cancer (IARC) are among the recipients of research grants awarded by the Neuroendocrine Tumor Research Foundation (NETRF), announced on 16 February. Dr Matthieu Foll, Dr Lynnette Fernandez-Cuesta, and their co-investigators in the “Reconciling lung carcinoids histopathological and molecular classifications” project were chosen to receive the funding through a competitive and rigorous peer-review process.

This research is part of the IARC lungNENomics project. The goal is to improve the diagnosis and treatment of neuroendocrine tumours of the lung. These tumours are rare, and most tend to grow slowly, but a significant number are more aggressive, reducing the 10-year overall survival rate to 50%. The researchers will use a combination of technologies such as artificial intelligence, molecular imaging, and spatial -omics data to better identify and classify aggressive tumours, enabling health-care professionals to better categorize patients in terms of prognosis and response to therapy. The data generated by this project may also lead to the identification of targets that influence treatment decisions about standard options and follow-up strategies.

NETRF named the “Reconciling lung carcinoids histopathological and molecular classifications” project as one of the most promising prospects to improve the understanding and treatment of neuroendocrine tumours. NETRF, which is based in the USA, is the leading private global funder of research on neuroendocrine tumours.

Read about the project on the NETRF website 

Read about the project on the website of the Rare Cancers Genomics initiative 

Publication status

Published in section: IARC News

Publication date: 17 February, 2023, 0:49

Direct link: https://www.iarc.who.int/news-events/iarc-scientists-awarded-grant-to-continue-research-on-neuroendocrine-tumours/

© Copyright International Agency on Research for Cancer 2024

Other news